1. THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch. (10th June 2014) Authors: Huffstutter, J.E.; Kafka, S.; Brent, L.H.; Matucci-Cerinic, M.; Tang, K.L.; Wang, J.; Decktor, D.D.; Chevrier, M.; Sprabery, T.; DeHoratius, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗